Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma
/in Hypernephroma, International Publications /von 2005-06-15 / Pediatr Blood Cancer 2005 Jun;44(7):679-81Natural-killer cells and dendritic cells: „l’union fait la force“
/in Dendritic Cells, International Publications /von 2005-06-02 / Blood 2005 Oct;106(7):2252-8[Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma]
/in Hepatocellular Carcinoma, International Publications /von 2005-06-01 / Zhonghua Gan Zang Bing Za Zhi 2005 Jun;13(6):432-5Vaccine therapy for non-Hodgkin’s lymphoma and other B-cell malignancies
/in International Publications, Malignant Lymphoma /von 2005-06-01 / Curr Opin Investig Drugs 2005 Jun;6(6):597-604[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]
/in International Publications, Newcastle Disease Virus /von 2005-06-01 / Zhonghua Gan Zang Bing Za Zhi 2005 Jun;13(6):467-8Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-06-01 / Clin. Cancer Res. 2005 Jun;11(11):4160-7Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine
/in Colorectal Cancer, International Publications /von 2005-06-01 / Cancer Res. 2005 Jun;65(11):4947-54Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
/in Colorectal Cancer, International Publications /von 2005-06-01 / Expert Rev Vaccines 2005 Jun;4(3):329-50
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution